FTH compared with DSGN: revenue, margins and what each company keeps, and the suppliers and customers both name

FTHFaeth Therapeutics, Inc.

Mkt capRevenueRevenue

DSGNDesign Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

FTHFaeth Therapeutics, Inc.

DSGNDesign Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

FTH: latest quarter not drawable. DSGN: latest quarter not drawable.Method ›

Price

rebased to 0%

FTH, solidDSGN, dashed

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only FTH 2

TAKTakeda Pharmaceuticalsupplier

—The Regents of the University of Californiaunlistedsupplier

Shared 0

No shared counterparties.

Only DSGN 4

—Wisconsin Alumni Research Foundation (WARF)unlistedsupplier

—Crossingunlistedsupplier

—Marlinspikeunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—TREF V Hidden Valley Ownerunlistedsupplier

FTHFaeth Therapeutics, Inc.

18.21▼−2.89%· post 18.32

Mkt cap$483.0M

DSGNDesign Therapeutics, Inc.

10.66▼−3.62%· post 10.66

ClosedOct 30 '26

Mkt cap$668.4M

Compare

ClosedOct 30 '26

FTHFaeth Therapeutics, Inc.

DSGNDesign Therapeutics, Inc.

18.21▼−2.89%post 18.32

Price

10.66▼−3.62%post 10.66

$483.0M

Mkt cap

$668.4M

FTH18.21▼−2.89%vsDSGN10.66▼−3.62%ClosedOct 30 '26